Asthma is a chronic inflammatory disease of the airways. Over the past 15 years, the number of Americans afflicted with asthma has more than doubled to over 14 million. The factors that predispose individuals to asthma, or lead to its development are actively studied; however, relatively little is known about the factors that govern the chronic nature of this disease. Adenosine is a signaling nucleoside that plays a role in chronic lung diseases such as asthma and chronic obstructive pulmonary diseases (COPD). However, very little is known about the mechanisms by which adenosine may impact these diseases. Adenosine deaminase (ADA) is a purine catabolic enzyme that controls the levels of adenosine in tissues and cells. Mice deficient in ADA develop severe lung inflammation and damage in association with elevated adenosine levels. During the previous funding period of this grant we showed that airway inflammation and remodeling in ADA-deficient lungs was very similar to the inflammation and damage seen in the lungs of asthmatics and COPD patients. Furthermore, we demonstrated that many of the phenotypes seen were due to increases in lung adenosine. The mechanisms by which adenosine directs these changes in the inflamed lung are not clear; however, recent findings have demonstrated that levels of the various adenosine receptors are increased in ADA-deficient lungs and the multifunctional cytokines IL-13 and IL-6 have been found to be upregulated, suggesting that these mediators may impact adenosine-mediated pulmonary phenotypes. Thus, the general hypothesis that will be tested in this proposal is that adenosine receptor signaling impacts chronic lung disease by the regulation of mediator production in the lung.
Four specific aims are designed to address this hypothesis:
Aim 1. Determine the importance of specific adenosine receptors in adenosine dependent lung inflammation and airway remodeling.
Aim 2. Investigate the function of the A3 adenosine receptor on eosinophils.
Aim 3. Examine the regulation and function of IL-13 in adenosine-mediated lung pathologies in ADA-deficient mice.
Aim 4. Examine the regulation and function of IL-6 in adenosine mediated lung pathologies in ADA-deficient mice. These studies will lead to a better understanding of adenosine's impact on the severity of chronic lung diseases such as asthma and COPD, which will help guide the development of novel therapies for their treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI043572-07
Application #
6849281
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Minnicozzi, Michael
Project Start
1998-07-01
Project End
2009-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
7
Fiscal Year
2005
Total Cost
$257,246
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Schneider, Daniel J; Lindsay, Janci C; Zhou, Yang et al. (2010) Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease. FASEB J 24:70-80
Polosa, Riccardo; Blackburn, Michael R (2009) Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci 30:528-35
Zhou, Yang; Schneider, Daniel J; Blackburn, Michael R (2009) Adenosine signaling and the regulation of chronic lung disease. Pharmacol Ther 123:105-16
Zhou, Yang; Mohsenin, Amir; Morschl, Eva et al. (2009) Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor. J Immunol 182:8037-46
Reichelt, Melissa E; Shanu, Anu; Willems, Laura et al. (2009) Endogenous adenosine selectively modulates oxidant stress via the A1 receptor in ischemic hearts. Antioxid Redox Signal 11:2641-50
Joachims, Michelle L; Marble, Patrick A; Laurent, Aletha B et al. (2008) Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases. J Immunol 181:8153-61
Morschl, Eva; Molina, Jose G; Volmer, Jonathan B et al. (2008) A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 39:697-705
Zhai, Yuxin; Zhong, Zhenping; Chen, Chyi-Ying A et al. (2008) Coordinated changes in mRNA turnover, translation, and RNA processing bodies in bronchial epithelial cells following inflammatory stimulation. Mol Cell Biol 28:7414-26
Mohsenin, Amir; Burdick, Marie D; Molina, Jose G et al. (2007) Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease. FASEB J 21:1026-36
Young, Hays W J; Williams, Olatunji W; Chandra, Divay et al. (2007) Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5'elements. Am J Respir Cell Mol Biol 37:273-90

Showing the most recent 10 out of 36 publications